Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer

  • Authors:
    • Ryoji Nonaka
    • Junichi Nishimura
    • Yoshinori Kagawa
    • Hideki Osawa
    • Junichi Hasegawa
    • Kohei Murata
    • Shu Okamura
    • Hirofumi Ota
    • Mamoru Uemura
    • Taishi Hata
    • Ichiro Takemasa
    • Tsunekazu Mizushima
    • Daisuke Okuzaki
    • Hirofumi Yamamoto
    • Yuichiro Doki
    • Masaki Mori
  • View Affiliations

  • Published online on: September 24, 2014     https://doi.org/10.3892/or.2014.3515
  • Pages: 2354-2358
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Serum microRNAs (miRNAs) have been shown to have potential for cancer diagnosis. The main objective of the present study was to identify a novel serum miRNA biomarker from patients with colorectal cancer (CRC). Microarray analysis of miRNA expression was performed using paired pre-operative and post-operative serum from 10 CRC patients. Expression of two miRNAs (let-7a and miR-199a-3p) was significantly decreased in the post-operative serum when compared to levels in the pre-operative serum (P=0.015 and 0.029, respectively). Quantitative real-time polymerase chain reaction (qRT-PCR) confirmed the decrease in the miRNAs in an extended number (n=30) of paired serum samples. Next, we examined the serum let-7a level in 32 non-cancer patients and 84 CRC patients but we found no significant difference (P=0.120). In contrast, miR199a-3p expression was significantly higher in the CRC patients than that in the non-cancer patients (P=0.016). Furthermore, clinical and pathological survey indicated that high expression of miR-199a-3p was significantly associated with deep wall invasion. Our data suggest that circulating miR-199a-3p could be a novel serum biomarker for CRC.
View Figures
View References

Related Articles

Journal Cover

December-2014
Volume 32 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nonaka R, Nishimura J, Kagawa Y, Osawa H, Hasegawa J, Murata K, Okamura S, Ota H, Uemura M, Hata T, Hata T, et al: Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer. Oncol Rep 32: 2354-2358, 2014
APA
Nonaka, R., Nishimura, J., Kagawa, Y., Osawa, H., Hasegawa, J., Murata, K. ... Mori, M. (2014). Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer. Oncology Reports, 32, 2354-2358. https://doi.org/10.3892/or.2014.3515
MLA
Nonaka, R., Nishimura, J., Kagawa, Y., Osawa, H., Hasegawa, J., Murata, K., Okamura, S., Ota, H., Uemura, M., Hata, T., Takemasa, I., Mizushima, T., Okuzaki, D., Yamamoto, H., Doki, Y., Mori, M."Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer". Oncology Reports 32.6 (2014): 2354-2358.
Chicago
Nonaka, R., Nishimura, J., Kagawa, Y., Osawa, H., Hasegawa, J., Murata, K., Okamura, S., Ota, H., Uemura, M., Hata, T., Takemasa, I., Mizushima, T., Okuzaki, D., Yamamoto, H., Doki, Y., Mori, M."Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer". Oncology Reports 32, no. 6 (2014): 2354-2358. https://doi.org/10.3892/or.2014.3515